Please Enable Cookies

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LENSAR, Inc. - Common Stock (NQ:LNSR)

14.06 +0.01 (+0.07%)
Streaming Delayed Price Updated: 1:30 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 70,805
Open 13.99
Bid (Size) 14.05 (2)
Ask (Size) 14.09 (9)
Prev. Close 14.05
Today's Range 13.99 - 14.11
52wk Range 2.951 - 17.31
Shares Outstanding 11,102,611
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (Nasdaq - GB)
From Brodsky & Smith LLC
Via GlobeNewswire

Performance

YTD
+61.8%
+61.8%
1 Month
-0.4%
-0.4%
3 Month
+26.3%
+26.3%
6 Month
+158.0%
+158.0%
1 Year
+368.7%
+368.7%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (Nasdaq - LNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSE - DNB), Global Blue Group Holding AG (NYSE - GB)
From Brodsky & Smith LLC
Via GlobeNewswire
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
From Kahn Swick & Foti, LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AZEK, LNSR, DNB on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Alcon Eyes Surgical Edge With LENSAR Buyout: Details
Via Benzinga
LENSAR - Top Healthcare Equipment Stock
Via Talk Markets
Topics Stocks / Equities
Earnings Scheduled For February 27, 2025
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Alcon Agrees to Acquire LENSAR, Inc.
From Alcon Inc. Investors
Via Business Wire
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Via FinancialNewsMedia
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
From LENSAR, Inc.
Via Business Wire
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Via InvestorPlace
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
LENSAR Reports First Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire

Frequently Asked Questions

Is LENSAR, Inc. - Common Stock publicly traded?
Yes, LENSAR, Inc. - Common Stock is publicly traded.
What exchange does LENSAR, Inc. - Common Stock trade on?
LENSAR, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for LENSAR, Inc. - Common Stock?
The ticker symbol for LENSAR, Inc. - Common Stock is LNSR on the Nasdaq Stock Market
What is the current price of LENSAR, Inc. - Common Stock?
The current price of LENSAR, Inc. - Common Stock is 14.06
When was LENSAR, Inc. - Common Stock last traded?
The last trade of LENSAR, Inc. - Common Stock was at 04/30/25 01:30 PM ET
What is the market capitalization of LENSAR, Inc. - Common Stock?
The market capitalization of LENSAR, Inc. - Common Stock is 156.10M
How many shares of LENSAR, Inc. - Common Stock are outstanding?
LENSAR, Inc. - Common Stock has 156M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.